Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

40.20
+0.53001.34%
Post-market: 40.200.00000.00%16:10 EDT
Volume:142.13K
Turnover:5.71M
Market Cap:263.31M
PE:- -
High:40.62
Open:39.88
Low:39.65
Close:39.67
52wk High:41.49
52wk Low:22.18
Shares:6.55M
Float Shares:6.55M
Volume Ratio:1.38
T/O Rate:2.17%
Dividend:0.28
Dividend Rate:0.70%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

GlucoTrack subsidiary initiates clinical trial manufacturing for LT-100

TIPRANKS
·
Aug 25

Sagimet Biosciences advances AURORA clinical trial

TIPRANKS
·
Aug 25

Moderna upgraded to Peer Perform from Underperform at Wolfe Research

TIPRANKS
·
Aug 25

Binance launches 5 stock perpetuals with 20x leverage

cryptonews
·
Aug 25

Viavi Solutions (VIAV) Could Be 40% Undervalued On Vertex 6.0 Launch

Simply Wall St.
·
Aug 25

Moderna's Landmark mRNA Cancer Vaccine Trial Success Ignites Biotech Sector Rally, Valuation Reset May Be Just Beginning

Stock News
·
Aug 25

Moderna Inc. Stock Slides 4.3%, Underperforms Peers

Dow Jones
·
Aug 25

Savara announces presentations of Results from Phase 3 trial of Molgramostim

TIPRANKS
·
Aug 25

Oruka Therapeutics Names Todd Edwards Chief Commercial Officer

Reuters
·
Aug 25

Moderna Inc Stock (MRNA) Moved Down by 5.13% on Aug 24: A Full Analysis

TradingKey
·
Aug 25

Moderna is Betting Big on Its Cancer Vaccine. This is What Wall Street Wants to See.

Dow Jones
·
Aug 24

Renalytix Discloses Director’s Link to Trellus Administration as KidneyIntelX Rollout Advances

TIPRANKS
·
Aug 24

U.S. Stocks on the MOVE-Jersey Mike's Sub, Moderna, PDD Holding

Reuters
·
Aug 24

BriaCell advances melanoma immunotherapy vaccine candidate Bria-MEL+

TIPRANKS
·
Aug 24

Barclays Raises Moderna PT on 'transformative' Melanoma Vaccine Potential

Reuters
·
Aug 24

Barclays Adjusts Price Target on Moderna to $125 From $48

MT Newswires Live
·
Aug 24

Moderna price target raised to $125 from $48 at Barclays

TIPRANKS
·
Aug 24

BUZZ-US Stocks Weekly: Rate Rattle

Reuters
·
Aug 24

Ribomic Completes Site Network for Phase 3 Achondroplasia Trial in Japan

TIPRANKS
·
Aug 24

Is Viavi Solutions (VIAV) Quietly Recasting Its 6G Moat With the Vertex 6.0 Launch?

Simply Wall St.
·
Aug 24